Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: i pose a question, that may or maynot be easy to answer ,

RE: "Licensing, licensing, licensing, with revenues returned via dividends."

Results over the past few years (M&A) have demonstrated that dividends, returning most all of the earnings to stock holders, would be the best way to increase shareholder value. That is if we ever have decent & regular earnings.

Share
New Message
Please login to post a reply